ENTRY       D10753            Mixture   Drug
NAME        Atazanavir and cobicistat;
            Evotaz (TN)
  ABBR      ATV/c
PRODUCT     EVOTAZ (E.R. Squibb & Sons)
COMPONENT   (Atazanavir sulfate [DR:D01276] | Atazanavir [DR:D07471]), Cobicistat [DR:D09881]
CLASS       Antiviral
             DG03107  Anti-HIV agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01641  CYP2C8 inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
             DG02887  UGT1A1 inhibitor
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
             DG02862  ABCG2 inhibitor
             DG02865  SLCO1B1 inhibitor
             DG02907  SLCO1B3 inhibitor
REMARK      ATC code: J05AR15
            Product: D10753<US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
COMMENT     Atazanavir is an inhibitor of CYP3A and UGT1A1 and a weak inhibitor of CYP2C8.
            Cobicistat is an inhibitor of CYP3A and CYP2D6. The transporters that cobicistat inhibits include P-glycoprotein (P-gp), BCRP, OATP1B1 and OATP1B3.
            Atazanavir and cobicistat are CYP3A4 substrates.
TARGET      HIV protease [KO:K22599]
  PATHWAY   ko03230(K22599)  Viral genome structure
            ko03250(K22599)  Viral life cycle - HIV-1
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION CYP inhibition: CYP3A [HSA:1576 1577 1551], CYP2D6 [HSA:1565]; CYP2C8 [HSA:1558]
            Enzyme inhibition: UGT1A1 [HSA:54658]
            Transporter inhibition: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR15 Atazanavir and cobicistat
                  D10753  Atazanavir and cobicistat &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Atazanavir Sulfate/ Cobicistat
                D10753  Atazanavir and cobicistat
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D10753  Atazanavir and cobicistat
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10753  Atazanavir and cobicistat
             Metabolizing enzyme inhibitor
              DG01641  CYP2C8 inhibitor
               D10753  Atazanavir and cobicistat
              DG01645  CYP2D6 inhibitor
               D10753  Atazanavir and cobicistat
              DG02852  CYP3A/CYP3A4 inhibitor
               D10753  Atazanavir and cobicistat
              DG02887  UGT1A1 inhibitor
               D10753  Atazanavir and cobicistat
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D10753  Atazanavir and cobicistat
              DG02862  ABCG2 inhibitor
               D10753  Atazanavir and cobicistat
              DG02865  SLCO1B1 inhibitor
               D10753  Atazanavir and cobicistat
              DG02907  SLCO1B3 inhibitor
               D10753  Atazanavir and cobicistat
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D10753  Atazanavir and cobicistat
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                D10753  Atazanavir and cobicistat &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10753
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10753
             Drug transporters
              D10753
DBLINKS     PubChem: 273220349
///
